Duane Boise & MMJ's team DEA approval imminent to grow Pharma quality cannabis скачать в хорошем качестве

Duane Boise & MMJ's team DEA approval imminent to grow Pharma quality cannabis

Duane Boise, MMJ BioPharma Labs, MMJ BioPharma Cultivation, and MMJ International Holdings, is in negotiations with a publicly traded international pharmaceutical company to collaborate on execution of its planed cannabis clinical trials and drug development. Recently President Biden signed into law the Marijuana Research and Expansion Act which will expedite schedule 1 researchers applications for DEA approval to research and development of eventual FDA approved drugs. These DEA approved physicians and researchers will significantly expand the customer base of the MMJ companies because they will need consistent reproducibly cannabis drugs. MMJ triad of companies, the leader in he field of federally legal research, pharmaceutical drug development, and cultivation of high quality marijuana is on the brink of creating a revolutionary product to help treat Huntington's disease and Multiple Sclerosis. With MMJ's DEA approval imminent to grow Pharma quality cannabis the market is on the verge of a radical transformation. As anecdotal evidence mounts as to the many benefits of cannabis it has drawn the attention of Big Pharma. Evidenced by the two recent acquisitions by Pfizer of Arena Pharmaceutical for $6.7 billion and Jazz Pharmaceuticals acquisition of GW for $7.2 billion.